WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 2'0701 Infant (under 12 months) mortality rate: 142
GDP / capita (US$): 3'4241 Child (under 5 years) mortality rate: 162

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 3'514  3'543  3'573  3'604  3'637  4'107  4'364  4'010 
Births 43  44  44  45  45  48  81  85 
Surviving infants 42  43  44  44  44  47  78  81 
Pop. less than 5 years 222  223  215  210  204  255  427  378 
Pop. less than 15 years 583  589  596  609  625  974  1'218  1'072 
Female 15-49 years 928  945  962  978  993  1'096  1'101  1'074 

Number of reported case

(Click for retrospective incidence data for Republic of Moldova (the))
Diphtheria 10 
Japanese encephalitis
Measles 11  687  3'242 
Mumps 131  143  144  292  29'783  1'942 
Pertussis 92  102  31  47  30  169  266 
Polio*
Rubella 2'803 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Republic of Moldova (the))
Vaccine year result method % card seen                                                
BCG 2004  100  DHS   89.7  99  98  98  99  99  99 
DTP1 2004  98  DHS   89.7  91  96  93  95  96  94 
DTP3 2004  94  DHS   89.7  92  93  90  94  95  95 
HepB_BD          99  99  99  99  99  93 
HepB3 2004  95  DHS   89.7  94  96  98  95  98  92 
Hib3          90  78  63  94 
JapEnc         
MCV 2004  91  DHS   89.7  91  91  97  91  94  89 
MCV2          95  97  98  98  97 
PCV1         
PCV3         
Pol3 2004  95  DHS   89.7  92  96  97  95  97  97 
Rota1          94 
Rota_last          93 
Rubella1          91  91  97  91  95 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Republic of Moldova (the))
BCG 99  98  98  96  99  99 
DTP1 97  96  93  88  96  98 
DTP3 92  93  90  85  95  95 
HepB3 94  96  98  89  98  92 
Hib3 90  78  63  47 
MCV 91  91  97  90  94  89 
PCV3
Pol3 92  96  97  87  97  97 
Rota_last 21 

Number of districts in the country 44  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 86
From 80 to 89% 9
From 50 to 79% 5
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 2 days; 7 years; Yes
DT 7 years; Yes
DTwP 22 months; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HepB birth; Yes and adults
Influenza Yes
MMR 12 months; 7, 15 years; Yes
OPV 2, 4, 6, 22 months; 7, 15 years; Yes
Pneumo_conj Yes From July 2013
Rotavirus 2, 4 months; Yes From April 2012
Td 15, 20, 25, 30, 35, 40, 50, 60 years; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2006-2010  2006-2010  2006-2010  2006-2010  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 44  44  44  44  44  44  44 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR No  No  No         

System performance

Total number of districts in country number 44  44  44  44  43  44  44 
Nº districts with DTP3 coverage >=80% number 42  42  40  38  41  42  44 
% of districts with DTP3 coverage >=80% From 0 to 100% 95  95  91  86  95  95  100 
Nº districts with measles (MCV1) coverage >=95% number 22  30  37  25  32     
% of districts with MCV1 coverage >=95% From 0 to 100% 50  68  84  57  74     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 535    58  54  56  94  84 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.